Global patterns of Hodgkin lymphoma incidence and mortality in 2020 and a prediction of the future burden in 2040

Int J Cancer. 2022 Jun 15;150(12):1941-1947. doi: 10.1002/ijc.33948. Epub 2022 Feb 7.

Abstract

Our study examines global patterns of Hodgkin lymphoma (HL) in 2020 and predicts the future incidence and mortality burden in 2040 using IARC's GLOBOCAN estimates of the number of new cases and deaths of HL in 185 countries. A total of 83 000 new cases of HL and 23 000 deaths from HL were estimated in 2020. In general, incidence and mortality rates were consistently higher in males (50% more cases and deaths than females) across world regions and countries. Incidence rates varied markedly by world region, at least 10-fold in both sexes, with the highest incidence rates observed in Southern Europe. Mortality exhibited an inverse pattern compared to incidence, with rates elevated in Western Asia and Northern Africa. The number of HL incident cases is predicted to rise to around 107 000 cases (a 30% increase) by 2040 due to demographic changes, assuming global rates in 2020 remains unchanged. The findings provide a baseline and impetus for developing strategies that aim to reduce the burden of HL in future decades.

Keywords: GLOBOCAN; Hodgkin lymphoma; IARC; epidemiology; neoplasm; registries.

MeSH terms

  • Europe / epidemiology
  • Female
  • Forecasting
  • Global Health
  • Hodgkin Disease* / epidemiology
  • Humans
  • Incidence
  • Male
  • Mortality